Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsDivislaboratories

    Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More

    Jump to

    • Buy Sanghi Industries, Axis Bank, Natco Pharma: Mitesh Thacker

      According to Mitesh Thacker of miteshthacker.com, one can buy Sanghi Industries, Axis Bank and Natco Pharma.

    • Buy Divis Laboratories, Infosys, Maruti Suzuki: Sandeep Wagle

      Sandeep Wagle of powermywealth.com is of the view that one can buy Divis Laboratories, Infosys and Maruti Suzuki.

    • Exit Marksans Pharma, says Rajat Bose

      Rajat Bose of rajatkbose.com suggests exiting Marksans Pharma.

    • Buy Adani Ports, Divis Laboratories: Mitesh Thacker

      Mitesh Thacker of miteshthacker.com is of the view that one can buy Adani Ports and Divis Laboratories.

    • Buy Divis Labs, Power Grid; sell Aurobindo Pharma: Thacker

      Mitesh Thacker of miteshthacker.com is of the view that one can buy Divis Labs and Power Grid and sell Aurobindo Pharma.

    • Buy Divis Labs, Adani Ports, Coal India: Sudarshan Sukhani

      According to Sudarshan Sukhani of s2analytics.com, Divis Laboratories, Adani Ports and Coal India are buying opportunities.

    • Sun Pharma best among pharma stocks, Biocon may hit Rs 845: Bose

      Rajat Bose of rajatkbose.com is of the view that Sun Pharma is the best stocks in pharma space and feels that Biocon may hit Rs 845.

    • Buy Divi's Labs & Godrej Industries: Manoj Murlidharan

      In an interview to CNBC-TV18, Manoj Murlidharan of Religare Securities shared his readings and outlook on Futures and Options (F&O) side of the market, specific stocks and sectors.

    • Go long in HPCL, Divis Labs; sell Mindtree: Ashish Kyal

      Ashish Kyal of wavesstrategy.com recommends buying HPCL and Divis Labs and advises selling Mindtree.

    • Buy Torrent Pharma, Divis Lab, LIC Housing, Adani Ports: Sukhani

      According to Sudarshan Sukhani of s2analytics.com, one can buy Torrent Pharma, Divis Labs, LIC Housing Finance and Adani Ports.

    • Buy Aurobindo Pharma; hold JSW Energy: Ashish Chaturmohta

      Ashish Chaturmohta of Sanctum Wealth Management is of the view that one can buy Aurobindo Pharma and Divis Labs and hold JSW Energy.

    • Tulsian on Ricoh India: Rush for exit, there is no hope

      In an interview to CNBC-TV18, SP Tulsian of sptulsian.com shared his reading and outlook on the fundamental side of the market as well as on specific stocks and sectors.

    • Buy Motherson Sumi, TVS Motor, Divis Labs: Rahul Mohindar

      Rahul Mohindar of viratechindia.com recommends buying Motherson Sumi Systems, TVS Motor Company and Divis Labs.

    • Go long in Reliance Industries, short Nifty: Amit Gupta

      Amit Gupta, Head- Derivatives at ICICIdirect recommends going long in Reliance Industries and hsort Nifty.

    • Here are SP Tulsian's top trading ideas

      In an interview to CNBC-TV18's Anuj Singhal and Sonia Shenoy, SP Tulsian of sptulsian.com shared his reading and outlook on the market and also gave recommendations on various stocks.

    • Buy Divis Labs, Maruti Suzuki, Coal India: Sudarshan Sukhani

      Sudarshan Sukhani of s2analytics.com is of the view that one can buy Divis Laboratories, Maruti Suzuki and Coal India.

    • Buy YES Bank, prefer GAIL, Divis Labs: Sudarshan Sukhani

      Sudarshan Sukhani of s2analytics.com is of the view that one can buy YES Bank and prefers GAIL India and Divis Labs.

    • Bull's Eye: Buy Idea, Mindtree, Ceat, Praj Ind; sell Biocon

      Sameet Chavan of Angel Broking is of the view that one may buy Ceat with a target of Rs 840.

    • Bull's Eye: Buy Bajaj Auto, Exide, DLF; sell Apollo Tyres

      Sameet Chavan of Angel Broking advises buying Bajaj Auto with a target of Rs 2850.

    • Divis Lab, Glenmark look weak; buy Bharti Airtel: Rajat Bose

      According to Rajat Bose of rajatkbose.com, Divis Laboratories and Glenmark Pharma are looking pretty weak.

    • Bull's Eye: Buy Tata Global, UPL, Wockhardt, Voltas, Divis Lab

      Manish Sharma of derivativetradingresearch.com is of the view that one may buy Tata Global with a target of Rs 128.

    • Short Aurobindo Pharma, buy Tata Chemical: Kunal Bothra

      Kunal Bothra of LKP Securities is of the view that one may sell Aurobindo Pharma.

    • Short Divis Lab, buy IndusInd Bank: Rahul Shah

      Rahul Shah of Motilal Oswal recommends shorting Divis Lab and advises buying IndusInd Bank.

    • Sell Arvind, PC Jeweller; buy Idea Cellular, Divis Lab: Sukhani

      Sudarshan Sukhani of s2analytics.com is of the view that one can buy Idea Cellular and Divis Lab and advises selling Arvind and PC Jeweller.

    • Six stocks that can give handsome returns on May 5

      Sameet Chavan of Angel Broking recommends buying Hindustan Unilever with a target of Rs 870 and advises selling Ashok Leyland with a target of Rs 98.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347